Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02366949
Title Phase I Study of Oral BAY 1217389 in Combination With Intravenous Paclitaxel
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bayer

Advanced Solid Tumor

triple-receptor negative breast cancer


BAY1217389 + Paclitaxel


Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.